Tresquare Technologies is pioneering a new approach to TAVI-in-TAVI procedures for degenerated aortic bioprostheses. Its platform is designed to mechanically resect and remove calcified leaflets before a transcatheter valve is implanted, a potential game-changer in improving haemodynamic outcomes and expanding treatment options where traditional approaches fall short.
Our conversation with Co-founders Stefano Pasquino and Mauro Ferraro revealed a lot about why current TAVI Valve-in-Valve procedures are failing patients and how they are not only creating a new technology - but creating a new life-saving procedure.
🔗 Learn more about Tresquare Technologies
🎧 Listen on Spotify
